Childrens language will tend to improve over time, and without controlled studies, it can be hard to know how much of observed change is down to a specific treatment. There is, however, increasing evidence that direct 1:1 intervention with an SLT/P can be effective for improving vocabulary and expressive language. There have been few studies of interventions that target receptive language, though some positive outcomes have been reported. How to help a child with developmental language disorder
Talk to the child often to help them learn new words
Read to them every day. Point out words you see
Point to signs in the grocery store, at school, and outside
Speak to the child in the language you know best
Listen and answer when the child talks
Get the child to ask you questions
Give the child time to answer questions
Keep them in school: children who are school-refusers have poorer language skills overall, and a higher incidence of language impairments

Outcome
Longitudinal studies indicate that problems are largely resolved by five years of age in around 40% of four-year-olds with early language delays who have no other presenting risk factors. However, for children who still have significant language difficulties at school entry, reading problems are common, even for children who receive specialist help, and educational attainments are typically poor. Poor outcomes are most common in cases where comprehension as well as expressive language is affected.
Naftifine hydrochloride (brand names include Exoderil and Naftin) is an allylamine antifungal drug for the topical treatment of tinea pedis, tinea cruris, and tinea corporis (topical fungal infections). Naftifine has triple action: antifungal, antibacterial, and anti-inflammatory. Its fungistatic activity is believed to be based on inhibition of the squalene-2,3-epoxidase enzyme, which in turn results in the shortage of ergosterol required for the formation of fungal cell membranes. With some fungal species, there is also fungicidal activity from a resulting accumulation of squalenes, leading to damage of the fungal cell membranes, including at the endoplasmatic reticulum. The half-life is approximately 2–3 days. The metabolites are excreted in the urine and feces.Naftifine was invented at the Sandoz Research Institute in Vienna, Austria. It was the first succesful antifungal medication of the allylamine class. Naftifine shows mostly fungicidal activity toward dematophytes and molds, and mostly fungistatic activity toward yeasts. It is also effective as an antibacterial agent in treating pyoderma. Naftifine is almost completely metabolized in the human body, with a half-life of 2–3 days. Its metabolytes do not have antifungal activity, and they are excreted with urine and bile. == References ==